Miller BL - Search Results

1

Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration.

Scherling CS, Hall T, Berisha F, Klepac K, Karydas A, Coppola G, Kramer JH, Rabinovici G, Ahlijanian M, Miller BL, Seeley W, Grinberg LT, Rosen H, Meredith J Jr, Boxer AL. Scherling CS, et al. Among authors: miller bl. Ann Neurol. 2014 Jan;75(1):116-26. doi: 10.1002/ana.24052. Epub 2014 Jan 2. Ann Neurol. 2014. PMID: 24242746 Free PMC article.

2

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

Motter R, Vigo-Pelfrey C, Kholodenko D, Barbour R, Johnson-Wood K, Galasko D, Chang L, Miller B, Clark C, Green R, et al. Motter R, et al. Ann Neurol. 1995 Oct;38(4):643-8. doi: 10.1002/ana.410380413. Ann Neurol. 1995. PMID: 7574461

3

Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease.

Vigo-Pelfrey C, Seubert P, Barbour R, Blomquist C, Lee M, Lee D, Coria F, Chang L, Miller B, Lieberburg I, et al. Vigo-Pelfrey C, et al. Neurology. 1995 Apr;45(4):788-93. doi: 10.1212/wnl.45.4.788. Neurology. 1995. PMID: 7723971

4

Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease.

Galasko D, Clark C, Chang L, Miller B, Green RC, Motter R, Seubert P. Galasko D, et al. Neurology. 1997 Mar;48(3):632-5. doi: 10.1212/wnl.48.3.632. Neurology. 1997. PMID: 9065538 Clinical Trial.

5

The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia.

Geschwind D, Karrim J, Nelson SF, Miller B. Geschwind D, et al. Ann Neurol. 1998 Jul;44(1):134-8. doi: 10.1002/ana.410440122. Ann Neurol. 1998. PMID: 9667603 Clinical Trial.

6

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles L, Boss MA, Seubert P. Galasko D, et al. Arch Neurol. 1998 Jul;55(7):937-45. doi: 10.1001/archneur.55.7.937. Arch Neurol. 1998. PMID: 9678311 Clinical Trial.

7

Frontotemporal dementia.

Rosen HJ, Lengenfelder J, Miller B. Rosen HJ, et al. Neurol Clin. 2000 Nov;18(4):979-92. doi: 10.1016/s0733-8619(05)70235-8. Neurol Clin. 2000. PMID: 11072270 Review.

8

Patterns of cerebral atrophy in primary progressive aphasia.

Rosen HJ, Kramer JH, Gorno-Tempini ML, Schuff N, Weiner M, Miller BL. Rosen HJ, et al. Among authors: miller bl. Am J Geriatr Psychiatry. 2002 Jan-Feb;10(1):89-97. Am J Geriatr Psychiatry. 2002. PMID: 11790639

9

Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD.

Schuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, Kramer J, Jagust W, Miller B, Wolkowitz OM, Yaffe K, Weiner MW. Schuff N, et al. Neurology. 2002 Mar 26;58(6):928-35. doi: 10.1212/wnl.58.6.928. Neurology. 2002. PMID: 11914410 Free PMC article.

10

Very early-onset familial Alzheimer's disease: a novel presenilin 1 mutation.

Goldman JS, Reed B, Gearhart R, Kramer JH, Miller BL. Goldman JS, et al. Among authors: miller bl. Int J Geriatr Psychiatry. 2002 Jul;17(7):649-51. doi: 10.1002/gps.657. Int J Geriatr Psychiatry. 2002. PMID: 12112163

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,591 results

Search Page

Filters